| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |